Detailed information for compound 669155
Basic information
Technical information
- TDR Targets ID: 669155
- Name: 5-[(2,4-dimethoxyphenyl)methylidene]-3-(2-met hylpropyl)-1,3-thiazolidine-2,4-dione
- MW: 321.391 | Formula: C16H19NO4S
-
H donors: 0
H acceptors: 2
LogP: 3.65
Rotable bonds: 5
Rule of 5 violations (Lipinski): 1 - SMILES: COc1cc(OC)ccc1C=C1SC(=O)N(C1=O)CC(C)C
- InChi: 1S/C16H19NO4S/c1-10(2)9-17-15(18)14(22-16(17)19)7-11-5-6-12(20-3)8-13(11)21-4/h5-8,10H,9H2,1-4H3/b14-7-
- InChiKey: OAANQNRDCDUJGB-AUWJEWJLSA-N
Network
Hover on a compound node to display the structore
Synonyms
- (5Z)-5-[(2,4-dimethoxyphenyl)methylidene]-3-(2-methylpropyl)-1,3-thiazolidine-2,4-dione
- 5-[(2,4-dimethoxyphenyl)methylene]-3-isobutyl-thiazolidine-2,4-dione
- (5Z)-5-[(2,4-dimethoxyphenyl)methylene]-3-isobutyl-thiazolidine-2,4-dione
- (5Z)-5-[(2,4-dimethoxyphenyl)methylene]-3-isobutylthiazolidine-2,4-dione
- 5-[(2,4-dimethoxyphenyl)methylene]-3-isobutylthiazolidine-2,4-dione
- (5Z)-5-(2,4-dimethoxybenzylidene)-3-isobutyl-thiazolidine-2,4-quinone
- 5-(2,4-dimethoxybenzylidene)-3-isobutyl-thiazolidine-2,4-quinone
- ZINC01181789
Targets
Known targets for this compound
No curated genes were found associated with this compound
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Echinococcus multilocularis | geminin | 0.0196 | 0.4696 | 1 |
| Trypanosoma brucei | inositol phosphorylceramide synthase | 0.0277 | 0.7706 | 0.5 |
| Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.007 | 0 | 0.5 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0339 | 1 | 0.5 |
| Schistosoma mansoni | hypothetical protein | 0.0196 | 0.4696 | 1 |
| Toxoplasma gondii | aldehyde dehydrogenase | 0.007 | 0 | 0.5 |
| Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0165 | 0.3544 | 0.5 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Treponema pallidum | fructose-bisphosphate aldolase | 0.0339 | 1 | 0.5 |
| Brugia malayi | hypothetical protein | 0.0175 | 0.3904 | 0.5 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Giardia lamblia | Fructose-bisphosphate aldolase | 0.0339 | 1 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0175 | 0.3904 | 0.5 |
| Onchocerca volvulus | 0.0175 | 0.3904 | 0.5 | |
| Schistosoma mansoni | hypothetical protein | 0.0196 | 0.4696 | 1 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Echinococcus granulosus | geminin | 0.0196 | 0.4696 | 1 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0165 | 0.3544 | 1 |
| Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0339 | 1 | 1 |
| Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0165 | 0.3544 | 1 |
Activities
No activities found for this compound.
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- Search by Saint Jude
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.